From Science to Sales — The Hard Truths of Commercializing Diagnostics Today - Mark Oldroyd
This week on Diagnosing Dx, I’m joined by Mark Oldroyd, a commercialisation strategist with over 30 years in healthcare, including leadership roles at Foundation Medicine, Tempus, and C2i Genomics.
Mark has guided diagnostics and omics companies across the US, Europe, and Asia, helping them find the right path from breakthrough science to a sustainable business.
🔥What You’ll Learn:
• Why moving from science to market in diagnostics is harder than it looks
• How funding, reimbursement, and market conditions shape your strategy
• Why sometimes starting small is the smartest move
• The role of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.